Potential Role and Impact of Peripheral Blood Mononuclear Cells in Radiographic Axial Spondyloarthritis-Associated Endothelial Dysfunction

Endothelial dysfunction (ED) is well known as a process that can lead to atherosclerosis and is frequently presented in radiographic axial spondyloarthritis (r-axSpA) patients. Here, we investigated cellular and molecular mechanisms underlying r-axSpA-related ED, and analyzed the potential effect of...

ver descrição completa

Detalhes bibliográficos
Autores: Ruiz-Limon, Patricia, Ladehesa-Pineda, Maria L., Lopez-Medina, Clementina, López-Pedrera, Chary, Abalos-Aguilera, Maria C., Barbarroja, Nuria, Arias-Quiros, Isabel, Perez-Sanchez, Carlos, Arias-de la Rosa, Ivan, Ortega-Castro, Rafaela, Escudero-Contreras, Alejandro, Collantes-Estevez, Eduardo, Jimenez-Gomez, Yolanda
Formato: artículo
Fecha de publicación:2021
País:España
Recursos:Instituto de Salud Carlos III (ISCIII)
Repositorio:Repisalud
Idioma:inglés
OAI Identifier:oai:repisalud.isciii.es:20.500.12105/18365
Acesso em linha:http://hdl.handle.net/20.500.12105/18365
Access Level:acceso abierto
Palavra-chave:Endothelium
Circulating mononuclear cells
Inflammation
Oxidative stress
Radiographic axial spondyloarthritis
Endotelio
Leucocitos mononucleares
Inflamación
Estrés oxidativo
Espondiloartrite axial
Humans
Leukocytes, Mononuclear
Cardiovascular Diseases
Risk Factors
Atherosclerosis
Oxidative Stress
Lymphocytes
Phenotype
Spondylarthritis
Spondylitis, Ankylosing
Descrição
Resumo:Endothelial dysfunction (ED) is well known as a process that can lead to atherosclerosis and is frequently presented in radiographic axial spondyloarthritis (r-axSpA) patients. Here, we investigated cellular and molecular mechanisms underlying r-axSpA-related ED, and analyzed the potential effect of peripheral blood mononuclear cells (PBMCs) in promoting endothelial injury in r-axSpA. A total of 30 r-axSpA patients and 32 healthy donors (HDs) were evaluated. The endothelial function, inflammatory and atherogenic profile, and oxidative stress were quantified. In vitro studies were designed to evaluate the effect of PBMCs from r-axSpA patients on aberrant endothelial activation. Compared to HDs, our study found that, associated with ED and the plasma proatherogenic profile present in r-axSpA, PBMCs from these patients displayed a pro-oxidative, proinflammatory, and proatherogenic phenotype, with most molecular changes noticed in lymphocytes. Correlation studies revealed the relationship between this phenotype and the microvascular function. Additional in vitro studies confirmed that PBMCs from r-axSpA patients promoted endothelial injury. Altogether, this study suggests the relevance of r-axSpA itself as a strong and independent cardiovascular risk factor, contributing to a dysfunctional endothelium and atherogenic status by aberrant activation of PBMCs. Lymphocytes could be the main contributors in the development of ED and subsequent atherosclerosis in this pathology.